SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016171
Filing Date
2023-09-29
Accepted
2023-09-29 17:00:37
Documents
18
Period of Report
2023-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20230929x8k.htm   iXBRL 8-K 49916
2 EX-4.1 capr-20230929xex4d1.htm EX-4.1 118375
3 EX-5.1 capr-20230929xex5d1.htm EX-5.1 20353
4 EX-10.1 capr-20230929xex10d1.htm EX-10.1 208975
5 EX-99.1 capr-20230929xex99d1.htm EX-99.1 12088
6 GRAPHIC capr-20230929xex5d1001.jpg GRAPHIC 4436
7 GRAPHIC capr-20230929xex99d1001.jpg GRAPHIC 5626
  Complete submission text file 0001558370-23-016171.txt   619462

Data Files

Seq Description Document Type Size
8 EX-101.SCH capr-20230929.xsd EX-101.SCH 3120
9 EX-101.LAB capr-20230929_lab.xml EX-101.LAB 15266
10 EX-101.PRE capr-20230929_pre.xml EX-101.PRE 9654
12 EXTRACTED XBRL INSTANCE DOCUMENT capr-20230929x8k_htm.xml XML 4682
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 231296460
SIC: 2834 Pharmaceutical Preparations